Texas Bank & Trust’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
VCM
VPM
Texas Bank & Trust's BMY Position: Q1 2026 in Review
Texas Bank & Trust reduced its Bristol-Myers Squibb (BMY) stake by 7.1% in Q1 2026, selling an estimated $37.3K and leaving 8,435 shares worth $512K. The position accounts for 0.19% of the portfolio, ranked #112.
Texas Bank & Trust first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $747K in Q4 2024. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.
- Texas Bank & Trust held 8,435 shares of Bristol-Myers Squibb worth $512K as of Q1 2026.
- Texas Bank & Trust sold 640 Bristol-Myers Squibb shares in Q1 2026, an estimated $37.3K.
- Bristol-Myers Squibb made up 0.19% of Texas Bank & Trust's portfolio in Q1 2026, its #112 holding.
- Texas Bank & Trust first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
- Texas Bank & Trust's Bristol-Myers Squibb position peaked at $747K in Q4 2024.
- 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.
Based on Texas Bank & Trust's 13F filing for Q1 2026, filed 30 Apr 2026.